祖父江 嘉洋

Medicine & Life Sciences

1. Atrial Fibrillation 100%
2. Heart Failure 51%
3. Pressure 31%
4. Ventricular Premature Complexes 29%
5. Coronary Vessels 27%
6. Sarcoidosis 26%
7. Confidence Intervals 26%
8. Heart Diseases 23%
9. Stroke Volume 21%
10. Myocardial Perfusion Imaging 21%
11. Anti-Arrhythmia Agents 18%
12. Hemorrhage 18%
13. Ventricular Tachycardia 18%
14. Electrocardiography 18%
15. Optical Fibers 17%
16. Semiconductors 17%
17. Tachycardia 17%
18. Central Sleep Apnea 16%
19. Takotsubo Cardiomyopathy 16%
20. Mortality 16%
21. Systolic Heart Failure 16%
22. Percutaneous Coronary Intervention 16%
23. Rivaroxaban 16%
24. Coronary Stenosis 15%
25. Lead 15%
26. Cardiac Arrhythmias 15%
27. Eicosapentaenoic Acid 15%
28. Cardiac Resynchronization Therapy 15%
29. Coronary Artery Disease 14%
30. Entropy 14%
31. Safety 14%
32. Stroke 14%
33. Thromboembolism 13%
34. Amyloidosis 13%
35. Hyperemia 13%
36. Isotopes 13%
37. Angiography 12%
38. Proteinuria 11%
39. Blood Pressure 11%
40. Hospital Mortality 11%
41. Acute Kidney Injury 11%
42. Warfarin 11%
43. Aspirin 11%
44. Cause of Death 10%
45. Risk Assessment 10%
46. Heart Rate 9%
47. Pathologic Constriction 9%
48. Cardiovascular Diseases 9%
49. Data Analysis 9%
50. Area Under Curve 9%